key: cord-0987550-xm02ydmm authors: Li, Jingyi; Mo, Chunfen; Guo, Yifan; Zhang, Bowen; Feng, Xiao; Si, Qiuyue; Wu, Xiaobo; Zhao, Zhe; Gong, Lixin; He, Dan; Shao, Jichun title: Roles of peptidyl-prolyl isomerase Pin1 in disease pathogenesis date: 2021-01-19 journal: Theranostics DOI: 10.7150/thno.45889 sha: f7de2890a1869b8e79129c62300d337bda9794d6 doc_id: 987550 cord_uid: xm02ydmm Pin1 belongs to the peptidyl-prolyl cis-trans isomerases (PPIases) superfamily and catalyzes the cis-trans conversion of proline in target substrates to modulate diverse cellular functions including cell cycle progression, cell motility, and apoptosis. Dysregulation of Pin1 has wide-ranging influences on the fate of cells; therefore, it is closely related to the occurrence and development of various diseases. This review summarizes the current knowledge of Pin1 in disease pathogenesis. Some proteins exhibit either a cis or a trans state due to the presence of proline, which imparts distinct conformations and biological functions. The peptidylprolyl cis-trans isomerases (PPIases) superfamily [1] comprises four families according to their structural differences: cyclophilins, FK506-binding proteins (FKBPs), parvulins, and the protein phosphatase (PPase) 2A phosphatase activator (PTPA) [2] [3] [4] [5] [6] . In the human parvulin family, there are two genes: PIN1 and PIN4 [7] [8] [9] . The coded product of PIN1, PPIase NIMA-interacting 1 (Pin1) protein, was identified in 1996 by Lu et al. as a protein interacting with NIMA kinase [7] . PIN4 encodes the isoforms parvulin 14 (Par14) and parvulin 17 (Par17) [9, 10] . Parvulin 14 consists of 131 amino acids, while parvulin 17 is an N-terminal extended version of Par14 with an additional 25 amino acids. Among the three members of the human parvulin family, current research on the function of Pin1 and its role in disease pathogenesis is the most in-depth. Pin1 consists of 163 amino acid residues with a relative molecular mass of 18 kDa and contains 1 nuclear localization signal and 2 functional domains. The amino terminus (N-terminus) is the tryptophan-tryptophan central domain (WW domain), which is responsible for recognition and binding to the pSer/Thr-Pro motif of the substrate, while the C-terminal PPIase catalytic domain performs the function of cis-trans isomerization [7, 11] . The two domains are fastened by a flexible linker of 15 residues. Although they belong to the same family, Pin1 differs from parvulin-type PPIases in that Pin1 specifically catalyzes the isomerization of phosphorylated Ser-Pro or Thr-Pro (pSer-Pro or pThr-Pro) peptides, whereas Par14/Par17 show no preference for phosphorylated substrates [9, 12, 13] . Since Pin1 isomerizes phosphorylated substrates and phosphorylation and post-phosphorylation events play important roles in cell signaling pathways, Pin1 is involved in a variety of cellular processes such as cell cycle, cell proliferation, cell motility, and apoptosis [13] [14] [15] [16] [17] [18] . In most cases, Pin1 Ivyspring International Publisher functions as a molecular timer or switch that modulates proteins or entire signaling pathways. Dysregulation of Pin1 is closely related to the development of multiple diseases. In this review, we will discuss the role of Pin1 in the pathogenesis of various related diseases. Overall, Pin1 drives tumor progression and is negatively associated with clinical outcome in patients with cancer [19] [20] [21] . Pin1 has been shown to activate more than 50 oncogenic proteins and growth promoters and/or shut down at least 20 tumor suppressors and growth inhibitors through positive and negative feedback mechanisms [12, 22] (Table 1) . Most tumors exhibit overexpression and/or activation of Pin1 compared with corresponding normal tissues, including breast, prostate, lung, ovarian, gastric, esophageal, cervical, and brain tumors and melanoma [21, [23] [24] [25] . Expression of Pin1 in tumor cell lines cultured in vitro has also been found to be significantly higher than that in normal cell lines. Knockdown of the Pin1 gene inhibits cancer cell growth both in vitro and in vivo and results in cancer cell apoptosis [26, 27] . In addition, emerging evidence suggests that inhibitors targeting Pin1 have significant anti-cancer effects. These inhibitors include juglone [27, 28] , all-trans retinoic acid (ATRA) [29, 30] , 2-{[4-(4-tert-butylbenzenesulfonamido) -1-oxo-1,4dihydronaphthalen-2-yl] sulfanyl} acetic acid (KPT-6566) [31] , epigallocatechin-3-gallate (EGCG) [32] , PiB [33] , compound 20 [34] , compound 23a [35] , API-1 [36] , arsenic trioxide (ATO) [37] , and BJP-06-005-3 [38] . In a recent review [22] , Chen et al. elaborated on how Pin1 contributes to all ten hallmarks of cancer [39] by dysregulating multiple cancer-driving pathways at various levels. Pin1 induces angiogenesis by facilitating expression of VEGF and inhibition of Pin1 by RNAi significantly suppresses angiogenesis [40, 41] ; Pin1 sustains proliferative signaling and evades growth suppression by activating growthpromoting regulators and inactivating growthinhibitory regulators [22] ; Pin1 promotes migration and invasion by regulating NOTCH1 [42] , TGF-β [43] , β-catenin [44] , and BRD4 [45] ; Pin1 inhibits apoptosis of tumor cells by increasing the anti-apoptotic function of anti-apoptotic proteins and suppressing pro-apoptotic factors [46, 47] . This concept has recently been greatly expanded, demonstrating that overactivation of Pin1 disrupts the balance between carcinogenic proteins and tumor suppressors, which pushes cells towards carcinogenesis [12] (Figure 1 ). Atherosclerosis (AS) is a chronic disease and the main cause of coronary heart disease, cerebral infarction, and peripheral vascular disease [48] . The early stage of AS is mainly caused by endothelial dysfunction. Endothelial nitric oxide synthetase (eNOS) plays a key role in the control of blood pressure and prevention of atherosclerosis by producing the vasodilator and vascular protective molecule nitric oxide (NO) [49] . eNOS interacts with Pin1 in a phosphorylation-dependent manner in endothelial cells. Phosphorylation of eNOS at Ser 116 enhances this interaction, thus inhibiting eNOS activity and reducing NO release [50, 51] . Pin1 also drives diabetic vascular disease by causing mitochondrial oxidative stress and ROS production. Inhibition of Pin1 by gene silencing in human aortic endothelial cells (HAECs) or Pin1 knockout in mice was found to restore NO levels and relieve vascular dysfunction [52] . These results indicate that Pin1 reduces NO synthesis by inhibiting eNOS and, thus, exerts a negative effect in cardiovascular disease. However, in some conditions, Pin1 may protect vascular endothelial homeostasis. TGF-β stimulates synthesis of proteoglycan in vascular smooth muscle cells (VSMC), especially expression of disaccharide chain protein and extension of glycosaminoglycan (GAG) chain on biglycan, which increases lipoprotein binding and promotes early inflammation of atherosclerosis [53, 54] . It has been shown that Pin1 enhances degradation of Smad2/3 ubiquitin proteasome induced by Smurf2 and inhibits TGF-β signal transduction [55] , effectively preventing early occurrence of atherosclerosis [56] . Another study showed that Pin1 inhibition significantly suppresses NO production in human periodontal ligament cells (PDLCs) [57] . Taken together, Pin1 potentially plays a double-edged role in regulating the pathogenesis of cardiovascular diseases under different circumstances. Similarly, both overexpression and downregulation of Pin1 can reduce cardiac hypertrophy [58] . Further detailed investigations are needed to reveal the function of Pin1 in cardiovascular disease. Insulin dysregulation is associated with various metabolic diseases including obesity, NASH, and type 2 diabetes. Pin1 promotes insulin secretion of islet β cells by enhancing the activity of SIK2, and also promotes cell proliferation and transformation by regulating activation of AP1 and ERK1/2 induced by insulin through interaction with p70S6K [59, 60] . Pin1 also positively regulates insulin-induced phosphorylation of IRS-1: Pin1 deletion inactivates IRS-1, thus leading to insulin resistance [61] . It can be concluded that Pin1 is involved in these metabolic diseases partially by controlling insulin signaling. However, Pin1 interacts with or regulates other key molecules involved in metabolic diseases, including obesity-related factors AMPK [62] [63] [64] [65] , PPARγ [66] , and PRDM16 [67] ; osteoporosis-related factors Runx2 [68] [69] [70] and BMP2 [71] ; and Nash-related factors Smad2/Smad3 and the TGF-β1 pathway [72] . The detailed mechanisms by which Pin1 regulates metabolic diseases are summarized in other reviews [73, 74] . Although emerging evidence has shown that Pin1 directly or indirectly regulates neuronal proteins such as Tau, amyloid precursor protein (APP), and α-synuclein, the physiological functions of Pin1 in neurodegenerative diseases remain to be elucidated. For example, in Parkinson's disease (PD) and Huntington's disease (HD), Pin1 is a pro-apoptotic factor in the process of neuronal degeneration, and high levels of Pin1 expression have been found in the brain tissue of patients [75] [76] [77] [78] . In other studies, downregulation of Pin1 expression was found to increase the likelihood of developing Alzheimer's disease (AD), and low expression of Pin1 was found in patients with AD [74, [78] [79] [80] . Increased deposition of plaques and intracellular neurofibrillary tangles (NFTs) are the main mechanisms of AD pathogenesis. NFTs are microtubule aggregations produced by hyperphosphorylation of Tau protein [74] . Extracellular plaques are primarily composed of aggregates of amyloid-β-peptides (Aβ) derived from increased APP processing [74, 81, 82] . In the neuronal cells of patients with AD, Pin1 is usually underexpressed and exhibits a negative correlation with degeneration of neuronal fibers [83] . Pin1 catalyzes the conformational switch of GSK-3β-mediated phosphorylated Tau proteins from the dysfunctional cis structure to the functional trans structure, thus degrading Tau proteins [84] [85] [86] . Additionally, Pin1 catalyzes phosphorylation of APP Thr 668 -Pro from the cis to trans isomer and also transforms APP processing to healthy non-amyloid formation [84] . Pin1 can also directly inhibit activation of GSK-3β by binding to the phosphorylated Thr 330 -Pro motif of GSK-3β and catalyzing its isomerization [84, 87] . Evidence suggests that overexpression of Pin1 in mature neurons can prevent neurodegeneration caused by Tau hyperphosphorylation [79] . In general, events that decrease expression of Pin1 in the brain increase the likelihood of AD [88] (Figure 2A) . Lewy bodies (LBs) are the characteristic protein aggregates in tissues of PD. LBs are mainly composed of α-synuclein [89, 90] , which is an unfolded protein in the natural state but can be induced to form an insoluble α-synuclein aggregate in the pathological state [91, 92] . Synphilin-1 is a protein that can interact with α-synuclein; this interaction plays a very important role in the formation of LBs [93] [94] [95] . Co-expression of α-synuclein and synphilin-1 causes the formation of debris inclusion bodies in the cytoplasm [93, 96] . From immunohistochemical analysis of the brain tissue of patients with PD, Pin1 was found to be expressed in 50-60% of LBs and was co-located with α-synuclein in inclusion bodies [75] . Due to the absence of a pSer/Thr-Pro motif in α-synuclein, Pin1 cannot bind to free α-synuclein but affects α-synuclein through indirect effects [75, 97] . Under the phosphorylation mediated by casein kinase II (CKII), Pin1 binds to phosphorylated synphilin-1 through Ser 211 -Pro and Ser 215 -Pro motifs, thus indirectly interacting with α-synuclein [75] . Overexpression of Pin1 could inhibit degradation of α-synuclein, enhance the half-life and insolubility of α-synuclein, and contribute to the formation of debris inclusion bodies of α-synuclein [75] (Figure 2B) . Therefore, it can be speculated that inhibitors targeting Pin1 may alleviate the process of PD. HD is a neurodegenerative disease caused by repeated amplification of the gene encoding CAG in huntingtin protein (HTT) [98] . The mutant huntingtin protein (mHTT) forms an endonuclear inclusion by misfolding and aggregating [99, 100] . mHTT is toxic, and its aggregation causes glial proliferation of astrocytes and selective loss of striatal neurons [101, 102] . mHTT can also cause DNA damage in neurons (DDR) [103, 104] , which is a significant pathological feature of HD. Studies have found that p53 mediates this cytotoxicity in HD cells and transgenic animal models, while p53 inhibitors block this process [105] . mHTT promotes phosphorylation of p53 at Ser 46 through HIPK2 and PKCδ, making it a target for Pin1 binding and regulation [76] . Pin1-mediated p53 isolates from the apoptosis-inhibiting factor iASPP, thus promoting the activation cascade of p53 in striatal neurons and increasing neuronal apoptosis [76, 106] (Figure 2C) . Conversely, when Pin1 is silenced, p53 binds to iASPP regardless of mHTT expression and p53 fails to induce apoptosis, thereby preventing mHTT-dependent neurodegeneration [76] . Pin1 is also associated with DDR in the regulation of DNA double-strand fracture repair [107] . In one study, DNA damage signal intensity in Pin1-knockout mice was significantly reduced by 20% compared with that of the wild-type HD mouse model [77] . However, another study revealed that Pin1 is a negative regulator of mHTT aggregation and that Pin1 overexpression reduces mHTT aggregates in HEK293 cells [108] . Nevertheless, experimental results from human neuronal cells and HD mice suggest that Pin1 is a potential therapeutic target for HD treatment. Viruses are common pathogens that cause infectious diseases. When a virus invades a host, the host activates its own immune system to fight or clear the infection [109] . But there are proteins in the host that help the virus reduce resistance from the host or promote the viral infection process. Some studies have found that Pin1 is one of these proteins and is closely related to viral infections [20, [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] . infection [120] . Host protein Pin1 promotes HIV infection by mediating three key processes in the HIV replication cycle [121] [122] [123] (Figure 3A) . First, the HIV core relies on Pin1 to remove capsid proteins: The HIV core is composed of ribonucleic acid (RNA) molecules and capsid protein. When HIV infects a host, it must remove the capsid and release RNA for subsequent reverse transcription, replication, and other processes [124] . The extracellular signal-regulated kinase 2 (ERK2) specifically phosphorylates Ser 16 -Pro 17 residues on capsid proteins [124] . Pin1 then binds to the phosphorylated Ser 16 -Pro 17 motif, which rearranges the structure of the capsid protein and removes the capsid from the HIV core [125] . Second, Pin1 facilitates reverse transcription of the HIV genome: Reverse transcription of the HIV genome is an important step in the life cycle of HIV, as DNA produced by reverse transcription can be incorporated into the host genome [126] . Host protein A3G (APOBEC3G) induces mutations in DNA during reverse transcription, which limits HIV replication [127] . But Pin1 downregulates A3G expression and prevents A3G from entering HIV [128] . HIV infection increases phosphorylation of Pin1 at Ser 16 and enhances the inhibitory effect of Pin1 on A3G [111, 128] . Third, Pin1 helps integrate HIV cDNA into the host DNA: HIV needs to integrate its cDNA into the host genome to reliably transcribe its progeny RNA [129] . The cellular kinase JNK phosphorylates the pSer 57 motif of HIV integrase [130] . Pin1 then binds to the phosphorylated pSer 57 -Pro motif to activate and stabilize HIV integrase activity, which helps it insert the HIV cDNA into the host genome [130, 131] . In HTLV-1-infected cells, Tax activates the RB/E2F pathway to increase expression of Pin1, which maintains the stability of Tax. Pin1 binds to the Ser 160 -Pro motif of Tax after its phosphorylation by mitotic kinase, which enhances the ability of Tax to directly bind IKKγ, activate NF-κB signaling, and finally promote cell proliferation and tumor occurrence. (E) In HPV-infected cells, overexpression of Pin1 causes NF-κB nuclear retention and activation of STAT3. Viral protein E2 can target and enhance the activity of Pin1 to increase the likelihood of cancer caused by HPV infection. (F) The viral protein HBx is a trans-activator of liver cancer. HBx activates cyclin D1 and the signaling pathway Wnt/β-catenin. Pin1 binds to the Ser 41 -Pro motif of HBx, which stabilizes the activity of HBx and induces overexpression of cyclin D1 and β-catenin, thus promoting liver cancer in HBV infection. Hepatitis C virus (HCV) is the main pathogen of chronic hepatitis and hepatocellular carcinoma (HCC). HCV is an enveloped RNA virus [132] . The replication process of HCV depends mainly on the host cell cycle and requires participation of host proteins [133] . Pin1 has been shown to be a necessary cytokine for HCV replication and can increase HCV infection [114] . Overexpression of Pin1 increases intracellular HCV RNA and intracellular viral protein NS5A [114] . HCV proteins NS5A and NS5B contain phosphorylated Ser/Thr-Pro motifs and Pin1 specifically interacts with NS5A and NS5B in immunoprecipitation experiments. NS5B can also increase expression of Pin1 [114, 115] . In general, host protein Pin1 may be utilized to increase HCV replication and infection ( Figure 3B ). with Burkitt lymphoma and production of T-cell malignancies [134] . BALF5, the EBV DNA polymerase subunit, is a key enzyme that affects replication during EBV cleavage [135] . Pin1 has been shown to be an important factor in regulating EBV replication. BALF5 interacts with Pin1 in a phosphorylation-dependent manner at Thr 178 -Pro of the BALF5 subunit. In one study, Pin1 knockdown by shRNA significantly inhibited EBV replication [119] . Another study showed that Pin1 is overexpressed in all EBV-associated nasopharyngeal carcinoma (NPC) cells, xenografts, and primary tumors [20] . Overexpression of Pin1 induces tumor cell growth by promoting production of cyclin D1 and activating the MAPK/JNK pathway ( Figure 3C ). The Pin1 inhibitor Juglone has been shown to inhibit growth of nasopharyngeal carcinoma cells and induce their apoptosis [20] . Human T-cell leukemia virus type 1 (HTLV-1) is the pathogen that causes adult T-cell leukemia (ATL) [136] . The oncoprotein Tax encoded by HTLV-1 plays an important role in cell proliferation, viral gene replication, transformation, and tumor generation [137, 138] . Expression of Tax may cause overexpression of Pin1 in ATL [116, 118] . In cells infected by HTLV-1, Tax activates the E2F/RB pathway to increase transcription and expression of Pin1. Pin1 binds to the Tax phosphorylation motif pSer 160 -Pro in the presence of mitotic kinases. Pin1-regulated phosphorylated Tax then interacts with IKKγ to promote NF-κB activation [118, 139] . The activity of NF-κB plays an important role in cell transformation, cell proliferation and cancer development [140] . Pin1 can also inhibit both ubiquitination and lysosomal degradation of Tax, thus promoting its stability [116] (Figure 3D ). High-risk human papillomavirus (HR-HPV) is closely related to cervical cancer, with HPV16 being the most common subtype [141] . E2 protein is a factor that regulates viral replication and transcription and can be a marker for early HPV infection [142] . Cancers caused by HR-HPV infection may be associated with activation of transcription factors NF-κB and STAT3 [143] . Overexpression of Pin1 in cervical cancer can increase nuclear retention of NF-κB and promote transactivation of STAT3, further promoting the occurrence of cancer [144] [145] [146] . In one study, increased Pin1 expression in E2-transfected HEK293 cells was found to be not significant (0.3-fold increase); however, E2 was found to enhance the activity of Pin1 [117] . This data indicates that E2 regulates activation of transcription factors NF-κB and STAT3 by targeting the activity of Pin1 [117] , which further effects cancer progression ( Figure 3E ). Hepatitis B virus (HBV) is a common pathogen in hepatocellular carcinoma (HCC) and HBV-encoded protein HBx is a trans-activator of liver cancer [147] . A study found that overexpression of Pin1 was most common in HBV-related HCC, and the majority of cases showed co-expression of Pin1 and HBx [113] . HBx contains two phosphorylated Ser-Pro motifs that are potential targets for Pin1 [148, 149] . Pin1 binds to the phosphorylated Ser 41 -Pro motif of HBx, which increases HBx stability and transactivation [113, 149] . HBx activates the oncogenic transcription factor cyclin D1 and the β-catenin signaling pathway associated with oncogenesis [150] . Overexpression of Pin1 not only increases expression of cyclin D1 but also promotes intracellular accumulation of β-catenin in the Wnt/β-catenin signaling pathway [151, 152] . These two aspects can increase expression of oncogenes and promote occurrence of HCC in HBV infection ( Figure 3F ). In summary, Pin1 promotes most viral infectious diseases by two broad mechanisms: (1) Pin1 is directly involved in the life cycle of the virus to promote viral infection. For example, Pin1 is involved in core exuviation, reverse transcription, and integration of the virus in HIV infection [111] . In HCV infection, Pin1 is involved in viral RNA replication [114] . Pin1 is also involved in viral DNA replication in EBV infection [119] . (2) Pin1 enhances the stability and production of oncogenic proteins. For example, Pin1 increases the stability of Tax in HTLV-1 infection and mediates Tax transactivation of NF-κB factor [116, 118] . In HBV infection, Pin1 stabilizes the oncoprotein HBx and increases expression of oncogenic proteins cyclin D1 and catenin [112, 113] . In HPV infection, Pin1 is involved in increased activation of transcription factors STAT3 and NF-κB [117] . Pin1 also increases expression of the oncogenic protein cyclin D1 in EBV infection [20] . Tanaka et al. also found that dipentamethylene thiuram monosulfide, a specific inhibitor of Pin1, inhibited feline coronavirus (FCoV) replication [153] , suggesting that targeting Pin1 may provide new insights for antiviral therapy. In summary, our review illustrates the potential roles of Pin1 in several common diseases. Due to the overexpression of Pin1 in tumor tissues and its role in promoting tumor progression, drugs currently under development for targeting Pin1, including natural products, chemical compounds, and peptide drugs, are mainly focused on cancer treatment. Although Pin1 inhibitors have shown tumor suppressive effects in cell lines, animal models, and even clinical trials, some inhibitors reveal a Pin1-independent mechanism and the side effects have yet to be clarified. For example, Pin1 inhibitor KPT-6566 may exert anti-cancer effects through at least two simultaneously acting mechanisms: inhibition of Pin1 and ROS production [31] . API-1 shows significant anti-HCC activity, but its low water solubility and in vivo bioavailability limit its clinical application [154] . Researchers have also identified some compounds or peptides such as PEPTIDE [155] and benzothiophene [156, 157] that suppress Pin1 activity at nanomolar concentrations but are inactive in cell-based assays because of their poor membrane permeability. One potential countermeasure is to increase the membrane permeability of these compounds by optimizing their structure or looking for corresponding derivatives. Research on the application of Pin1 inhibitors and agonists in other related diseases is limited, and more detailed investigations need to be carried out for therapeutic potential, especially in diseases such as viral infection and AD in which the role of Pin1 is relatively clear. Studies on the upstream regulatory signals and downstream targets of Pin1 can also provide ideas for expanding treatment strategies for the above-mentioned diseases. Determination of enzymatic catalysis for the cis-trans-isomerization of peptide binding in proline-containing peptides The mode of action of peptidyl prolyl cis/trans isomerases in vivo: binding vs. catalysis Insights into the catalytic mechanism of peptidyl prolyl cis/trans isomerases The protein phosphatase 2A phosphatase activator is a novel peptidyl-prolyl cis/trans-isomerase Small family with key contacts: par14 and par17 parvulin proteins, relatives of pin1, now emerge in biomedical research Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins A human peptidyl-prolyl isomerase essential for regulation of mitosis Identification of eukaryotic parvulin homologues: a new subfamily of peptidylprolyl cis-trans isomerases Identification and characterization of a 14 kDa human protein as a novel parvulin-like peptidyl prolyl cis/trans isomerase Characterization of novel elongated Parvulin isoforms that are ubiquitously expressed in human tissues and originate from alternative transcription initiation Function of WW domains as phosphoserine-or phosphothreonine-binding modules The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation dependent Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer Phosphorylation-specific prolyl isomerization: is there an underlying theme? Inhibition of p66Shc-mediated mitochondrial apoptosis via targeting prolyl-isomerase Pin1 attenuates intestinal ischemia/reperfusion injury in rats Involvement of prolyl isomerase PIN1 in the cell cycle progression and proliferation of hepatic oval cells Landscape of Pin1 in the cell cycle The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer Overexpression of PIN1 Enhances Cancer Growth and Aggressiveness with Cyclin D1 Induction in EBV-Associated Nasopharyngeal Carcinoma Prevalent overexpression of prolyl isomerase Pin1 in human cancers Prolyl isomerase Pin1: a promoter of cancer and a target for therapy Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1 Pin1 is overexpressed and correlates with poor prognosis in gastric cancer The prolyl isomerase Pin1 is overexpressed in human esophageal cancer Involvement of Pin1 induction in epithelial-mesenchymal transition of tamoxifen-resistant breast cancer cells Pin1 Inhibitor Juglone Exerts Anti-Oncogenic Effects on LNCaP and DU145 Cells despite the Patterns of Gene Regulation by Pin1 Differing between These Cell Lines Juglone reduces growth and migration of U251 glioblastoma cells and disrupts angiogenesis Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways Chemical or genetic Pin1 inhibition exerts potent anticancer activity against hepatocellular carcinoma by blocking multiple cancer-driving pathways A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action Epigallocatechin-gallate suppresses tumorigenesis by directly targeting Pin1 Pin1 and Par14 peptidyl prolyl isomerase inhibitors block cell proliferation Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution Structure-guided design of alpha-amino acid-derived Pin1 inhibitors Targeting Pin1 by inhibitor API-1 regulates microRNA biogenesis and suppresses hepatocellular carcinoma development Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells Identification of a potent and selective covalent Pin1 inhibitor Hallmarks of cancer: the next generation Pin1 facilitates NF-kappaB activation and promotes tumour progression in human hepatocellular carcinoma Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer Pin1 promotes transforming growth factor-beta-induced migration and invasion Pin1 promotes prostate cancer cell proliferation and migration through activation of Wnt/beta-catenin signaling Prolyl isomerase PIN1 regulates the stability, transcriptional activity and oncogenic potential of BRD4 PIN1 inhibits apoptosis in hepatocellular carcinoma through modulation of the antiapoptotic function of survivin The peptidyl-prolyl isomerase Pin1 facilitates cytokine-induced survival of eosinophils by suppressing Bax activation Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis Nitric oxide synthases: regulation and function Pin1 prolyl isomerase regulates endothelial nitric oxide synthase Role of eNOS phosphorylation at Ser-116 in regulation of eNOS activity in endothelial cells Targeting prolyl-isomerase Pin1 prevents mitochondrial oxidative stress and vascular dysfunction: insights in patients with diabetes Transforming growth factor-beta regulation of proteoglycan synthesis in vascular smooth muscle: contribution to lipid binding and accelerated atherosclerosis in diabetes Hyperelongated biglycan: the surreptitious initiator of atherosclerosis Pin1 down-regulates transforming growth factor-beta (TGF-beta) signaling by inducing degradation of Smad proteins Peptidyl-prolyl isomerases: functionality and potential therapeutic targets in cardiovascular disease PIN1 inhibition suppresses osteoclast differentiation and inflammatory responses Pin1: a molecular orchestrator in the heart The prolyl isomerase Pin1 interacts with a ribosomal protein S6 kinase to enhance insulin-induced AP-1 activity and cellular transformation The prolyl isomerase Pin1 increases β-cell proliferation and enhances insulin secretion Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 associates with insulin receptor substrate-1 and enhances insulin actions and adipogenesis Prolyl isomerase Pin1 negatively regulates AMP-activated protein kinase (AMPK) by associating with the CBS domain in the γ subunit Whole body deletion of AMP-activated protein kinase {beta}2 reduces muscle AMPK activity and exercise capacity AMP-activated protein kinase (AMPK) beta1beta2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise Impaired skeletal muscle beta-adrenergic activation and lipolysis are associated with whole-body insulin resistance in rats bred for low intrinsic exercise capacity Pin1 enhances adipocyte differentiation by positively regulating the transcriptional activity of PPARγ Prolyl Isomerase Pin1 Suppresses Thermogenic Programs in Adipocytes by Promoting Degradation of Transcriptional Co-activator PRDM16 Prolyl isomerase Pin1-mediated conformational change and subnuclear focal accumulation of Runx2 are crucial for fibroblast growth factor 2 (FGF2)-induced osteoblast differentiation Pin1-mediated Runx2 modification is critical for skeletal development Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling Pin1 plays a critical role as a molecular switch in canonical BMP signaling Pin1 induction in the fibrotic liver and its roles in TGF-β1 expression and Smad2/3 phosphorylation Physiological and Pathogenic Roles of Prolyl Isomerase Pin1 in Metabolic Regulations via Multiple Signal Transduction Pathway Modulations Pin1 Modulation in Physiological Status and Neurodegeneration. Any Contribution to the Pathogenesis of Type 3 Diabetes? Prolylisomerase Pin1 accumulates in lewy bodies of parkinson disease and facilitates formation of alpha-synuclein inclusions Ser46 phosphorylation and prolyl-isomerase Pin1-mediated isomerization of p53 are key events in p53-dependent apoptosis induced by mutant huntingtin Effects of Pin1 Loss in Hdh(Q111) Knock-in Mice Structure and function of the human parvulins Pin1 and Par14/17 Prolyl isomerase Pin1 and neurotrophins: a loop that may determine the fate of cells in cancer and neurodegeneration Pin1 dysregulation helps to explain the inverse association between cancer and Alzheimer's disease Age-dependent metabolic dysregulation in cancer and Alzheimer's disease Proteolytic processing of Alzheimer's beta-amyloid precursor protein Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein Regulation of protein conformation by Pin1 offers novel disease mechanisms and therapeutic approaches in Alzheimer's disease Prolyl isomerase Pin1 promotes amyloid precursor protein (APP) turnover by inhibiting glycogen synthase kinase-3beta (GSK3beta) activity: novel mechanism for Pin1 to protect against Alzheimer disease Pin1 in Alzheimer's disease Alpha-synuclein in Lewy bodies Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein Alphasynuclein and Parkinson's disease Pathogenic effects of alpha-synuclein aggregation Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation Transfected synphilin-1 forms cytoplasmic inclusions in HEK293 cells The peptidyl-prolyl isomerase Pin1 A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology Neuropathological classification of Huntington's disease Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice DNA breakage and induction of DNA damage response proteins precede the appearance of visible mutant huntingtin aggregates Phosphorylation of huntingtin by cyclin-dependent kinase 5 is induced by DNA damage and regulates wild-type and mutant huntingtin toxicity in neurons p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP Prolyl isomerase PIN1 regulates DNA double-strand break repair by counteracting DNA end resection PIN1 Modulates Huntingtin Levels and Aggregate Accumulation: An In vitro Model Anti-immunology: evasion of the host immune system by bacterial and viral pathogens The Roles of the Unique Prolyl Isomerase Pin1 in Cancer-Related Viral and Bacterial Infections Pin1 liberates the human immunodeficiency virus type-1 (HIV-1): Must we stop it? PIN1 genetic polymorphisms and the susceptibility of HBV-related hepatocellular carcinoma in a Guangxi population Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis Peptidyl-prolyl isomerase Pin1 is a cellular factor required for hepatitis C virus propagation Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis The prolyl isomerase Pin1 stabilizes the human T-cell leukemia virus type 1 (HTLV-1) Tax oncoprotein and promotes malignant transformation HPV16 E2 enhances the expression of NF-kappaB and STAT3 target genes and potentiates NF-kappaB activation by inflammatory mediators Peptidylproline cis-trans-isomerase Pin1 interacts with human T-cell leukemia virus type 1 tax and modulates its activation of NF-kappaB Pin1 interacts with the Epstein-Barr virus DNA polymerase catalytic subunit and regulates viral DNA replication How does HIV cause AIDS? Phosphorylation of human immunodeficiency virus type 1 capsid protein at serine 16, required for peptidyl-prolyl isomerase-dependent uncoating, is mediated by virion-incorporated extracellular signal-regulated kinase 2 Cellular proteins in HIV virions Actin-binding cellular proteins inside human immunodeficiency virus type 1 Multiple roles of the capsid protein in the early steps of HIV-1 infection Uncoating of human immunodeficiency virus type 1 requires prolyl isomerase Pin1 Early stages of HIV replication: how to hijack cellular functions for a successful infection Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells Human immunodeficiency virus type 1 replication and regulation of APOBEC3G by peptidyl prolyl isomerase Pin1 HIV-1 replication from after cell entry to the nuclear periphery Concerted action of cellular JNK and Pin1 restricts HIV-1 genome integration to activated CD4+ T lymphocytes Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells Hepatitis C virus biology Virus-host cell interactions during hepatitis C virus RNA replication: impact of polyprotein expression on the cellular transcriptome and cell cycle association with viral RNA synthesis History of resaerch on Epstein-Barr virus--target cells of infection, and disease Further characterization of the interaction between the Epstein-Barr virus DNA polymerase catalytic subunit and its accessory subunit with regard to the 3'-to-5' exonucleolytic activity and stability of initiation complex at primer terminus HTLV-1, Immune Response and Autoimmunity Human T-cell leukemia virus type I and adult T-cell leukemia Characterization of T cells immortalized by Tax1 of human T-cell leukemia virus type 1 IKKgamma mediates the interaction of cellular IkappaB kinases with the tax transforming protein of human T cell leukemia virus type 1 NF-kappaB in cancer: from innocent bystander to major culprit Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia HPV16 E2 is an immediate early marker of viral infection, preceding E7 expression in precursor structures of cervical carcinoma Cervicovaginal coinfections with human papillomavirus and Chlamydia trachomatis Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection Pin1 is required for the Ser727 phosphorylation-dependent Stat3 activity Hepatitis B virus x protein and pin1 in liver cancer: "les liaisons dangereuses The enigmatic X gene of hepatitis B virus Peptidyl-Prolyl cis/trans Isomerase NIMA-Interacting 1 as a Therapeutic Target in Hepatocellular Carcinoma Hepatitis B virus X (HBx) play an anti-apoptosis role in hepatic progenitor cells by activating Wnt/beta-catenin pathway Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes Cellular peptidyl-prolyl cis/trans isomerase Pin1 facilitates replication of feline coronavirus MicroRNA Biogenesis is Enhanced by Liposome-Encapsulated Pin1 Inhibitor in Hepatocellular Carcinoma Structural basis for high-affinity peptide inhibition of human Pin1 Structure-based design of novel human Pin1 inhibitors (I) Structure-based design of novel human Pin1 inhibitors (II) Peptidyl-prolyl isomerase 1 (Pin1) serves as a coactivator of steroid receptor by regulating the activity of phosphorylated steroid receptor coactivator 3 (SRC-3/AIB1) Peptidyl-prolyl cis/trans isomerase Pin1 is critical for the regulation of PKB/Akt stability and activation phosphorylation The prolyl isomerase Pin1 increases β-cell proliferation and enhances insulin secretion Protein Never in Mitosis Gene A Interacting-1 regulates calpain activity and the degradation of cyclooxygenase-2 in endothelial cells Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1 Pin1 modulates chemo-resistance by up-regulating FoxM1 and the involvements of Wnt/β-catenin signaling pathway in cervical cancer Pinning down HER2-ER crosstalk in SMRT regulation The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylationdependent c-Myc protein degradation Critical role of XBP1 in cancer signalling is regulated by PIN1 Androgen receptor serine 81 mediates Pin1 interaction and activity Pin1 acts catalytically to promote a conformational change in Cdc25 The peptidyl-prolyl isomerase Pin1 regulates cytokinesis through Cep55 Pin1 interacts with in a phosphorylation-dependent manner and regulates its transactivation activity FAK phosphorylation by ERK primes ras-induced tyrosine dephosphorylation of FAK mediated by PIN1 and PTP-PEST Pin1, a new player in the fate of HIF-1α degradation: an hypothetical mechanism inside vascular damage as Alzheimer's disease risk factor Hyperthermia stress activates heat shock protein expression via propyl isomerase 1 regulation with heat shock factor 1 Essential role for the prolyl isomerase Pin1 in Toll-like receptor signaling and type I interferon-mediated immunity Down-regulation of myeloid cell leukemia-1 through inhibiting Erk/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer Phosphorylation stabilizes Nanog by promoting its interaction with Pin1 The prolyl isomerase Pin1 regulates the NF-kappaB signaling pathway and interleukin-8 expression in glioblastoma Ablation of a peptidyl prolyl isomerase Pin1 from p53-null mice accelerated thymic hyperplasia by increasing the level of the intracellular form of Notch1 Prolyl-isomerase Pin1 controls Notch3 protein expression and regulates T-ALL progression Dual function of Pin1 in NR4A nuclear receptor activation: enhanced activity of NR4As and increased Nur77 protein stability A distinct role for Pin1 in the induction and maintenance of pluripotency The TLR7/8 agonist CL097 primes N-formyl-methionyl-leucyl-phenylalanine-stimulated NADPH oxidase activation in human neutrophils: critical role of p47phox phosphorylation and the proline isomerase Pin1 A Pin1/mutant p53 axis promotes aggressiveness in breast cancer ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect Polo-like kinase 1-mediated phosphorylation stabilizes Pin1 by inhibiting its ubiquitination in human cells Inhibition of the peptidyl-prolyl-isomerase Pin1 enhances the responses of acute myeloid leukemia cells to retinoic acid via stabilization of RARalpha and PML-RARalpha Ras-induced and extracellular signal-regulated kinase 1 and 2 phosphorylation-dependent isomerization of protein tyrosine phosphatase (PTP)-PEST by PIN1 promotes FAK dephosphorylation by PTP-PEST The Rab2A GTPase promotes breast cancer stem cells and tumorigenesis via Erk signaling activation Regulation of Raf-1 by direct feedback phosphorylation TPA-induced cell transformation provokes a complex formation between Pin1 and 90 kDa ribosomal protein S6 kinase 2 The prolyl isomerase Pin1 interacts with a ribosomal protein S6 kinase to enhance insulin-induced AP-1 activity and cellular transformation Human chromosome segregation involves multi-layered regulation of separase by the peptidyl-prolyl-isomerase Pin1 Mitotic regulation of SEPT9 protein by cyclin-dependent kinase 1 (Cdk1) and Pin1 protein is important for the completion of cytokinesis Peptidyl-prolyl isomerase Pin1 markedly enhances the oncogenic activity of the rel proteins in the nuclear factor-kappaB family Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells A suppressive role of the prolyl isomerase Pin1 in cellular apoptosis mediated by the deathassociated protein Daxx Pin1-FADD interactions regulate Fas-mediated apoptosis in activated eosinophils Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma The peptidyl-isomerase Pin1 regulates p27kip1 expression through inhibition of Forkhead box O tumor suppressors Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1 Destabilization of KLF10, a tumor suppressor, relies on thr93 phosphorylation and isomerase association Degradation of the tumor suppressor PML by Pin1 contributes to the cancer phenotype of breast cancer MDA-MB-231 cells Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1 Prolyl isomerase Pin1 downregulates tumor suppressor RUNX3 in breast cancer Cdk2 and Pin1 negatively regulate the transcriptional corepressor SMRT Protective effect of nectandrin B, a potent AMPK activator on neointima formation: inhibition of Pin1 expression through AMPK activation ATR Plays a Direct Antiapoptotic Role at Mitochondria, which Is Regulated by Prolyl Isomerase Pin1 The peptidyl-prolyl isomerase Pin1 regulates the stability of granulocyte-macrophage colony-stimulating factor mRNA in activated eosinophils Bruton's tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer G protein-coupled receptor kinase 2 (GRK2) modulation and cell cycle progression The peptidyl-prolyl isomerase PIN1 relieves cyclin-dependent kinase 2 (CDK2) inhibition by the CDK inhibitor p27 Regulation of phosphatidylinositol-5-phosphate signaling by Pin1 determines sensitivity to oxidative stress Inhibition of CDK-mediated phosphorylation of Smad3 results in decreased oncogenesis in triple negative breast cancer cells Prolyl isomerase Pin1 negatively regulates the stability of SUV39H1 to promote tumorigenesis in breast cancer Essential role of Pin1 in the regulation of TRF1 stability and telomere maintenance Pin1 impairs microRNA biogenesis by mediating conformation change of XPO5 in hepatocellular carcinoma This work was supported by grants from the National Natural Science Foundation of China The authors have declared that no competing interest exists.